Side Effects Reported by Moroccan Medical Students Who Received COVID-19 Vaccines.

IF 1.1 Q4 PHARMACOLOGY & PHARMACY

Current drug safety Pub Date : 2024-01-01 DOI:10.2174/1574886318666230503113713

Badreddine Moukafih, Leila Belaroussi, Sanae Achour, Abdeslam El Kartouti

{"title":"Side Effects Reported by Moroccan Medical Students Who Received COVID-19 Vaccines.","authors":"Badreddine Moukafih, Leila Belaroussi, Sanae Achour, Abdeslam El Kartouti","doi":"10.2174/1574886318666230503113713","DOIUrl":null,"url":null,"abstract":"Background: Low confidence in the safety of COVID-19 vaccines was found to be a key promoter of vaccine reluctance especially among youth. Furthermore, young adults are an important demographic for building herd immunity through vaccination. As a result, their reactions to getting COVID-19 vaccines are crucial in our fight against SARS-CoV-2.Objective: The overall goal of this study was to look into the shortterm side effects experienced by Moroccan medical and pharmacy students after receiving COVID-19 vaccines.Methods: A cross-sectional survey-based study to assess the COVID-19 vaccines' short-term AEFIs among Moroccan medical and pharmacy students. The validated questionnaire was delivered in a digital form to explore the side effects (SE) they encountered after the first or the second dose of one of three vaccines namely: AstraZeneca Vaxzevria, PfizerBioNTeck, and SinoPharm vaccines.Results: There were 510 students in total who took part. After the first and second doses, approximately 72 percent and 78 percent of subjects, respectively, reported no SE. The remainder had localized injection site side effects (26%). Fatigue (21%), fever (19%), headache (17%), and myalgia (16%) were the most common systemic adverse effects after the first dose. There were no serious SEs reported.Conclusion: The majority of the reported AEFIs in our data were mild to moderate in intensity and lasted only one or two days. COVID-19 vaccinations are highly likely safe for young adults, according to the findings of this study.","PeriodicalId":10777,"journal":{"name":"Current drug safety","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574886318666230503113713","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Low confidence in the safety of COVID-19 vaccines was found to be a key promoter of vaccine reluctance especially among youth. Furthermore, young adults are an important demographic for building herd immunity through vaccination. As a result, their reactions to getting COVID-19 vaccines are crucial in our fight against SARS-CoV-2.

Objective: The overall goal of this study was to look into the shortterm side effects experienced by Moroccan medical and pharmacy students after receiving COVID-19 vaccines.

Methods: A cross-sectional survey-based study to assess the COVID-19 vaccines' short-term AEFIs among Moroccan medical and pharmacy students. The validated questionnaire was delivered in a digital form to explore the side effects (SE) they encountered after the first or the second dose of one of three vaccines namely: AstraZeneca Vaxzevria, PfizerBioNTeck, and SinoPharm vaccines.

Results: There were 510 students in total who took part. After the first and second doses, approximately 72 percent and 78 percent of subjects, respectively, reported no SE. The remainder had localized injection site side effects (26%). Fatigue (21%), fever (19%), headache (17%), and myalgia (16%) were the most common systemic adverse effects after the first dose. There were no serious SEs reported.

Conclusion: The majority of the reported AEFIs in our data were mild to moderate in intensity and lasted only one or two days. COVID-19 vaccinations are highly likely safe for young adults, according to the findings of this study.

查看原文本刊更多论文

接种 COVID-19 疫苗的摩洛哥医科学生报告的副作用。

背景：研究发现，对 COVID-19 疫苗安全性的信心不足是导致人们不愿接种疫苗的主要原因，尤其是在年轻人当中。此外，青壮年是通过接种疫苗建立群体免疫力的重要人群。因此，他们对接种 COVID-19 疫苗的反应对我们抗击 SARS-CoV-2 至关重要：本研究的总体目标是调查摩洛哥医科和药科学生接种 COVID-19 疫苗后的短期副作用：这是一项基于横断面调查的研究，旨在评估摩洛哥医学和药学专业学生接种 COVID-19 疫苗后的短期副作用。以数字形式发放经过验证的调查问卷，以了解他们在接种第一剂或第二剂三种疫苗中的一种疫苗后遇到的副作用 (SE)：结果显示：共有 510 名学生参与。在接种第一剂和第二剂疫苗后，分别约有 72% 和 78% 的受试者表示没有出现 SE。其余受试者的注射部位出现了局部副作用（26%）。疲劳（21%）、发烧（19%）、头痛（17%）和肌痛（16%）是第一剂后最常见的全身性不良反应。没有严重SE的报告：结论：在我们的数据中，大多数报告的 AEFI 为轻度至中度，且仅持续一到两天。根据这项研究的结果，COVID-19 疫苗接种对年轻人来说是非常安全的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current drug safety PHARMACOLOGY & PHARMACY-

CiteScore

2.10

自引率

0.00%

发文量

112

期刊介绍： Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.